205171-16-0

Upstream product

• 205171-04-6 (2R,3R,4R,5R)-5-((benzoyloxy)methyl)-2-(6-chloro-9H-purin-9-yl)-3-methyltetrahydrofuran-3,4-diyl dibenzoate 
• 205171-13-7 6-chloro-9H-(2-C-methyl-2,3-O-isopropylidene-β-D-ribofuranosyl)purine 
• 205171-05-7 6-chloro-9-(2-C-methyl-?2-D-ribofuranosyl)-9H-purine 
• 15397-15-6 1,2,3,5-tetra-O-benzoyl-2-C-methyl-β-D-ribofuranose 
• 87-42-3 6-chloropurine 
• 3718-88-5 3-iodobenzylamine hydrochloride 
• 205171-15-9 (3aR,4S,6R,6aR)-6-(6-Chloro-purin-9-yl)-2,2,6a-trimethyl-tetrahydro-furo[3,4-d][1,3]dioxole-4-carboxylic acid ethyl ester 
• 205171-14-8 (3aR,4S,6R,6aR)-6-(6-Chloro-purin-9-yl)-2,2,6a-trimethyl-tetrahydro-furo[3,4-d][1,3]dioxole-4-carboxylic acid 

Relevant academic research and scientific papers

2'-C-Methyl analogues of selective adenosine receptor agonists: Synthesis and binding studies

2'-C-Methyl analogues of selective adenosine receptor agonists such as (R)-PIA, CPA, CCPA, NECA, and IB-MECA were synthesized in order to further investigate the subdomain that binds the ribose moiety. Binding affinities of these new compounds at A1